Drug profile · INN
insulin neutral human
ACTRAPID
insulin neutral human (ACTRAPID) is a insulin receptor agonist. Associated with NovoThirteen.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — insulin neutral human
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
insulin neutral human (ACTRAPID) is a insulin receptor agonist. Associated with NovoThirteen.
Key facts
INN insulin neutral human
Brand ACTRAPID
Mechanism Insulin receptor agonist
Target Insulin receptor
Originator NovoThirteen
Mechanism of action
Insulin receptor agonist
Primary target: Insulin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is insulin neutral human?
insulin neutral human (ACTRAPID) is a insulin receptor agonist. Associated with NovoThirteen.
What is the brand name for insulin neutral human?
ACTRAPID is a marketed brand name for insulin neutral human. Check FDA Drugs@FDA for the current US label holder and prescribing information.